This inventor holds 1 USPTO granted patent and 10 published patent applications and 1 EPO patent. Top assignees: Merck Sharp + Dohme Corp., Novartis Ag. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,405 
1 out of 3,978 
Years Active: 2018
Title: Axel Hoos: Innovator in Cancer Combination Therapies
Introduction
Axel Hoos is a prominent inventor based in Philadelphia, PA, known for his significant contributions to cancer treatment through innovative combination therapies. His work focuses on developing novel pharmaceutical compositions that enhance the efficacy of cancer treatments.
Latest Patents
Axel Hoos holds a patent for "Combination therapies for cancer." This patent describes a unique combination that includes a B-Raf inhibitor, specifically N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide or a pharmaceutically acceptable salt thereof, along with a MEK inhibitor and a PD-1 antagonist. The patent outlines methods for using these combinations in treating conditions where inhibiting MEK and/or B-Raf and/or immune modulation through PD-1 is beneficial, particularly in cancer.
Career Highlights
Throughout his career, Axel Hoos has worked with leading pharmaceutical companies, including Novartis AG and Merck Sharp & Dohme Corp. His experience in these organizations has allowed him to contribute significantly to the field of oncology and drug development.
Collaborations
Axel has collaborated with notable colleagues such as Elaine M. Pinheiro and Patrick Chun, enhancing the research and development of innovative cancer therapies.
Conclusion
Axel Hoos is a key figure in the advancement of cancer treatment through his innovative combination therapies. His patent and collaborations reflect his commitment to improving patient outcomes in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile